Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.09
-0.53 (-6.96%)
Dec 5, 2025, 4:00 PM EST - Market closed

Bioventus Revenue

Bioventus had revenue of $138.65M in the quarter ending September 27, 2025, a decrease of -0.23%. This brings the company's revenue in the last twelve months to $563.83M, up 1.58% year-over-year. In the year 2024, Bioventus had annual revenue of $573.28M with 11.89% growth.

Revenue (ttm)
$563.83M
Revenue Growth
+1.58%
P/S Ratio
0.83
Revenue / Employee
$606,268
Employees
930
Market Cap
474.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024573.28M60.94M11.89%
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020321.16M-18.98M-5.58%
Dec 31, 2019340.14M20.96M6.57%
Dec 31, 2018319.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings